878798-87-9 Usage
Uses
Used in Pharmaceutical Research:
2-Boc-1,2,3,4-Tetrahydroisoquinoline-8-Carboxylic Acid is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Drug Development:
2-Boc-1,2,3,4-Tetrahydroisoquinoline-8-Carboxylic Acid is employed in drug development as a building block for the creation of novel molecules with potential medicinal properties. Its presence in natural products suggests that it may have bioactive properties that can be harnessed for the treatment of various diseases.
Used in Biological Research:
2-Boc-1,2,3,4-Tetrahydroisoquinoline-8-Carboxylic Acid is used as a research tool in the study of biological processes. Its interaction with biological systems can provide insights into the mechanisms of action of various biologically active compounds, contributing to our understanding of disease pathways and potential therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 878798-87-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,7,9 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 878798-87:
(8*8)+(7*7)+(6*8)+(5*7)+(4*9)+(3*8)+(2*8)+(1*7)=279
279 % 10 = 9
So 878798-87-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H19NO4/c1-15(2,3)20-14(19)16-8-7-10-5-4-6-11(13(17)18)12(10)9-16/h4-6H,7-9H2,1-3H3,(H,17,18)
878798-87-9Relevant articles and documents
AZABENZIMIDAZOLE DERIVATIVES AS PI3K BETA INHIBITORS
-
Page/Page column 75, (2018/01/19)
The present invention relates to azabenzimidazole derivatives of Formula (I) (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active 10 ingredient as well as the use of said compounds as a medicament.